Sun, 22-May-2022

Biotechnology

Moderna, Pfizer Start Decisive COVID-19 Vaccine Tria...

Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on Monday. ... July 28, 2020 10:11 am By Neha Mule

Daiichi Sankyo and AstraZeneca Enter New Global Deve...

Daiichi Sankyo announced today that it has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo’s DS-1062, a TROP2 directed DXd antibody drug conjugate (ADC),... July 27, 2020 8:53 am By Neha Mule

Moderna Loses Challenge to Arbutus Patent on Vaccine...

Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, incl... July 24, 2020 10:36 am By Neha Mule

Daiichi Sankyo and Gustave Roussy Enter Innovative R...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Gustave Roussy today announced a multi-year, multi-study research collaboration to enrich and further enable the development of DS-1062 and patri... July 22, 2020 12:08 pm By Neha Mule

Moderna Phase 1 Results Show Coronavirus Vaccine Saf...

Moderna Inc’s experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Vo... July 15, 2020 9:32 am By Neha Mule

Dante Labs IMMENSA Receives CE-IVD Mark for Whole Ge...

Dante Labs received CE-IVD Mark for its IMMENSA Software for interpretation of whole genome sequencing data in a clinical setting at scale. IMMENSA was built leveraging more than 150,000 genomic reports genera... July 14, 2020 6:18 am By Neha Mule

HitGen and Morphic Extend Drug Discovery Research Co...

HitGen Inc. announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic. HitGen’s industry-le... July 6, 2020 6:50 am By Neha Mule

Related News